Reading the "T" Leaves of COVID-19 Vaccine Responses in Multiple Sclerosis
- PMID: 34880090
- DOI: 10.1212/WNL.0000000000013166
Reading the "T" Leaves of COVID-19 Vaccine Responses in Multiple Sclerosis
Comment in
-
Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies.Neurology. 2022 Feb 1;98(5):e541-e554. doi: 10.1212/WNL.0000000000013108. Epub 2021 Nov 22. Neurology. 2022. PMID: 34810244 Free PMC article.
Similar articles
-
Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?Int J Mol Sci. 2021 Apr 8;22(8):3859. doi: 10.3390/ijms22083859. Int J Mol Sci. 2021. PMID: 33917860 Free PMC article. Review.
-
Vaccination and multiple sclerosis in the era of the COVID-19 pandemic.J Neurol Neurosurg Psychiatry. 2021 Oct;92(10):1033-1043. doi: 10.1136/jnnp-2021-326839. Epub 2021 Aug 5. J Neurol Neurosurg Psychiatry. 2021. PMID: 34353858 Free PMC article. Review. No abstract available.
-
COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial.JAMA. 2022 Jan 11;327(2):115. doi: 10.1001/jama.2021.24118. JAMA. 2022. PMID: 35015052 No abstract available.
-
T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: "Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.".EBioMedicine. 2021 Dec;74:103692. doi: 10.1016/j.ebiom.2021.103692. Epub 2021 Nov 10. EBioMedicine. 2021. PMID: 34773893 Free PMC article. No abstract available.
-
COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis.Neurol Neuroimmunol Neuroinflamm. 2021 Nov 9;9(1):e1104. doi: 10.1212/NXI.0000000000001104. Print 2022 Jan. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34753828 Free PMC article.
Cited by
-
A retrospective evaluation of seroconversion after COVID-19 during the early Omicron wave in fully vaccinated multiple sclerosis patients receiving anti-CD20 therapies.Mult Scler Relat Disord. 2023 Mar;71:104574. doi: 10.1016/j.msard.2023.104574. Epub 2023 Feb 15. Mult Scler Relat Disord. 2023. PMID: 36827874 Free PMC article.
-
Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes.Mult Scler Relat Disord. 2022 Nov;67:104079. doi: 10.1016/j.msard.2022.104079. Epub 2022 Jul 28. Mult Scler Relat Disord. 2022. PMID: 35952457 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical